ACCL0933 A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
This randomized phase III trial studies caspofungin acetate to see how it works compared to
fluconazole in preventing invasive fungal infections in patients with acute myeloid leukemia
who are undergoing chemotherapy. Caspofungin acetate or fluconazole may help prevent fungal
infections caused by chemotherapy. It is not yet known whether fluconazole is more effective
than caspofungin acetate in preventing fungal infections in patients with acute myeloid
leukemia who are undergoing chemotherapy.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.